These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29255325)

  • 1. [Efficacy and safety of beclomethasone dipropionate HFA.].
    Capristo C; Rossi GA
    Recenti Prog Med; 2017 Nov; 108(11):1-11. PubMed ID: 29255325
    [No Abstract]   [Full Text] [Related]  

  • 2. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study.
    Wolthers OD; Walters EG
    Clin Ther; 2011 Aug; 33(8):1069-76. PubMed ID: 21784529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
    Fireman P; Prenner BM; Vincken W; Demedts M; Mol SJ; Cohen RM
    Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of once or twice daily inhalation of extrafine HFA beclomethasone dipropionate in patients with mild to moderate asthma.
    Gillissen A; Richter A; Oster H; Criée CP
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):233-41. PubMed ID: 18204133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qvar for Treatment of Chronic Asthma.
    Jayanth A
    Am Fam Physician; 2018 Apr; 97(8):538-539. PubMed ID: 29671500
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects on lung function, symptoms, and bronchial hyperreactivity of low-dose inhaled beclomethasone dipropionate given with HFA-134a or CFC propellant.
    Woodcock A; Williams A; Batty L; Masterson C; Rossetti A; Cantini L
    J Aerosol Med; 2002; 15(4):407-14. PubMed ID: 12581507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic activity of inhaled and swallowed beclomethasone dipropionate and the effect of different inhaler devices.
    Trescoli C; Ward MJ
    Postgrad Med J; 1998 Nov; 74(877):675-7. PubMed ID: 10197215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of beclomethasone dipropionate HFA 200 microg once daily in chronic obstructive pulmonary disease and bronchial asthma.
    Tatsis G; Kotsifas K; Filaditaki V; Makrantoni G; Boulia S
    J Int Med Res; 2007; 35(3):361-73. PubMed ID: 17593865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equivalence of asthma control with new CFC-free formulation HFA-134a beclomethasone dipropionate and CFC-beclomethasone dipropionate.
    Dahl R; Ringdal N; Ward SM; Stampone P; Donnell D
    Br J Clin Pract; 1997; 51(1):11-5. PubMed ID: 9158265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of HFA-134a beclomethasone dipropionate extra-fine aerosol over six months.
    Boulet LP; Cartier A; Ernst P; Larivée P; Laviolette M
    Can Respir J; 2004 Mar; 11(2):123-30. PubMed ID: 15045043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma.
    Papi A; Canonica GW; Maestrelli P; Paggiaro P; Olivieri D; Pozzi E; Crimi N; Vignola AM; Morelli P; Nicolini G; Fabbri LM;
    N Engl J Med; 2007 May; 356(20):2040-52. PubMed ID: 17507703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equivalence of hydrofluoroalkane (HFA) and chlorofluorocarbons (CFC) formulations of inhaled beclomethasone.
    Lipworth BJ; Jackson CM
    Respir Med; 2000 Feb; 94(2):177; author reply 179-80. PubMed ID: 10714427
    [No Abstract]   [Full Text] [Related]  

  • 13. Introduction. Nebulized beclometasone dipropionate therapy in asthma.
    Bousquet J; Delacourt C
    Respir Med; 2003 Feb; 97 Suppl B():S1-4. PubMed ID: 12593520
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma.
    Micheletto C; Guerriero M; Tognella S; Dal Negro RW
    Respir Med; 2005 Jul; 99(7):850-5. PubMed ID: 15939246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Corticoid therapy in asthma. Smaller particles--bigger effect].
    MMW Fortschr Med; 2004 Mar; 146(13):63. PubMed ID: 15219141
    [No Abstract]   [Full Text] [Related]  

  • 16. Targeting drug delivery and the small airways in asthma.
    Williams A
    Hosp Med; 1998 Jun; 59(6):488-91. PubMed ID: 9775278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bronchial asthma. Small bronchi are not spared].
    MMW Fortschr Med; 2002 May; 144(18):64. PubMed ID: 12422715
    [No Abstract]   [Full Text] [Related]  

  • 18. A systemic bioactivity comparison of double-strength and regular-strength beclomethasone dipropionate MDI formulations.
    Brannan MD; Herron JM; Reidenberg P; Affrime MB
    Ann Allergy Asthma Immunol; 1998 Jan; 80(1):39-44. PubMed ID: 9475565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy and safety of beclomethasone dipropionate inhalation capsules inhaled by Cyclohaler compared with Becotide Rotacaps inhaled by Rotahaler.
    Vink-van Wijngaarden T; Blom-Ross ME; Lansdorp D; Goedhart DM; Eelhart J; Guelen PJ; de Vos D
    Int J Clin Pharmacol Ther; 1998 Sep; 36(9):510-5. PubMed ID: 9760014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone diproprionate extrafine aerosol) in asthma (Part 2): Clinical experience in children.
    van Schayck CP; Donnell D
    Int J Clin Pract; 2004 Aug; 58(8):786-94. PubMed ID: 15372852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.